Concourse Financial Group Securities, Inc. Morpho Sys Ag Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$17.36 - $19.34 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$8.6 - $18.18 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$4.55 - $9.9 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$6.72 - $8.6 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$6.72 - $8.6 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$3.95 - $7.74 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$3.56 - $5.22 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$3.21 - $5.74 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$4.14 - $22.13 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$4.51 - $7.39 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$5.87 - $9.73 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$9.08 - $12.45 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$11.76 - $19.51 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	SELL	$18.95 - $23.95 $27,136 - $34,296	-1,432 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$21.56 - $30.66 $8,128 - $11,558	377 Added 35.73%	1,432 $31,000
Q4 2020 Feb 02, 2021	BUY	$24.81 - $30.33 $6,351 - $7,764	256 Added 32.04%	1,055 $30,000
Q3 2020 Nov 13, 2020	BUY	$30.28 - $35.72 $2,513 - $2,964	83 Added 11.59%	799 $25,000
Q2 2020 Aug 13, 2020	BUY	$24.08 - $33.35 $2,985 - $4,135	124 Added 20.95%	716 $23,000
Q1 2020 May 13, 2020	BUY	$18.86 - $37.36 $678 - $1,344	36 Added 6.47%	592 $15,000
Q4 2019 Feb 14, 2020	BUY	$26.07 - $36.32 $4,249 - $5,920	163 Added 41.48%	556 $20,000
Q3 2019 Nov 13, 2019	BUY	$24.18 - $31.58 $3,699 - $4,831	153 Added 63.75%	393 $11,000
Q2 2019 Aug 13, 2019	BUY	$23.24 - $26.76 $4,578 - $5,271	197 Added 458.14%	240 $6,000
Q1 2019 May 15, 2019	BUY	$22.55 - $29.84 $969 - $1,283	43 New	43 $0
Q4 2018 Feb 14, 2019	BUY	$21.96 - $31.02 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$26.64 - $35.66 $0 - $0	0 New	0 $0

Others Institutions Holding MOR

# of Institutions

Shares Held

1.8M

Call Options Held

Put Options Held

14.7K

View Full List

About MorphoSys AG

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

More about MOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account